Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alissa Visram

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Blood Cancer Journal|January 31, 2018
Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizersAlissa Visram, Christopher Bredeson, David Allan, et al.
Blood Advances|September 30, 2024
Quadruplet regimens for patients with newly diagnosed multiple myeloma: a systematic review and meta-analysisMohammad S Ebraheem, Rajshekhar Chakraborty, Bram Rochwerg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 31, 2022
The Association Between the Urine Protein-to-Albumin Gap and the Diagnosis of Multiple Myeloma: A Population-Based Retrospective Cohort StudyGregory L Hundemer, Haris Imsirovic, Alissa Visram, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 2, 2024
Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort StudyHira Mian, Hsien Seow, Gregory R Pond, et al.
Haematologica|July 13, 2023
Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort studyArleigh McCurdy, Hsien Seow, Gregory P Pond, et al.
American Journal of Hematology|October 17, 2020
Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantationIuliana Vaxman, Alissa Visram, Prashant Kapoor, et al.
American Journal of Hematology|August 29, 2025
Real-World Outcomes of Transplant Ineligible Older Adults With Multiple Myeloma Treated With Novel Regimens: A Population-Based Retrospective Cohort StudyNadine Abdallah, Hira Mian, Hsien Seow, et al.
Haematologica|February 5, 2026
Second primary malignancy in multiple myeloma: does a prior malignancy matter?Alissa Visram, Hsien Seow, Rajeshkar Chakraborty, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 5, 2025
Changes in Frailty Categorization Over One Year among Real-World Patients With Multiple Myeloma: A Prospective Cohort Study (MFRAIL)Imran Haider, Darryl P Leong, Omar Shahid, et al.
Blood Cancer Journal|April 20, 2022
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, MinnesotaGeffen Kleinstern, Dirk R Larson, Cristine Allmer, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Blood Cancer Journal|January 31, 2018
Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizersAlissa Visram, Christopher Bredeson, David Allan, et al.
Blood Advances|September 30, 2024
Quadruplet regimens for patients with newly diagnosed multiple myeloma: a systematic review and meta-analysisMohammad S Ebraheem, Rajshekhar Chakraborty, Bram Rochwerg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 31, 2022
The Association Between the Urine Protein-to-Albumin Gap and the Diagnosis of Multiple Myeloma: A Population-Based Retrospective Cohort StudyGregory L Hundemer, Haris Imsirovic, Alissa Visram, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 2, 2024
Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort StudyHira Mian, Hsien Seow, Gregory R Pond, et al.
Haematologica|July 13, 2023
Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort studyArleigh McCurdy, Hsien Seow, Gregory P Pond, et al.
American Journal of Hematology|October 17, 2020
Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantationIuliana Vaxman, Alissa Visram, Prashant Kapoor, et al.
American Journal of Hematology|August 29, 2025
Real-World Outcomes of Transplant Ineligible Older Adults With Multiple Myeloma Treated With Novel Regimens: A Population-Based Retrospective Cohort StudyNadine Abdallah, Hira Mian, Hsien Seow, et al.
Haematologica|February 5, 2026
Second primary malignancy in multiple myeloma: does a prior malignancy matter?Alissa Visram, Hsien Seow, Rajeshkar Chakraborty, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 5, 2025
Changes in Frailty Categorization Over One Year among Real-World Patients With Multiple Myeloma: A Prospective Cohort Study (MFRAIL)Imran Haider, Darryl P Leong, Omar Shahid, et al.
Blood Cancer Journal|April 20, 2022
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, MinnesotaGeffen Kleinstern, Dirk R Larson, Cristine Allmer, et al.
Pageof 8